• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Acrose
    / Rafa

    Active Ingredient
    Acarbose 50 mg, 100 mg

    Status in Israel

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft


    30 x 50 mg

    partial basket chart 18667 9385


    30 x 100 mg

    partial basket chart 18666 9386

    Related information


    See prescribing information for full details.


    NIDDM in patients inadequately controlled by diet alone, or on diet and oral hypoglycemic agents.


    Hypersensitivity, pregnancy, lactation, chronic digestive system disorders, liver function disorders, renal insufficiency.
    See literature for full details.

    Special Precautions

    When a high dosage is taken or when the medicdbine is taken concomitantly with other anti-diabetic medicdbations, hypoglycemia may occur, in which case glucose/dextrose should be administered rather than sucrose. May cause elevation in liver enzymes. Therefore, liver enzymes should be monitored during the first 6-12 months of treatment. Safety and efficacy in children under 18 years have not been established.

    Side Effects

    Increased flatulence, diarrhea, other abdominal aches. See literature for full details.

    Drug interactions

    Sulfonylureas, metformin, insulin, cholestyramine, digoxin, intestinal absorbents, and digestive enzyme preparations, activated charcoal preparations, neomycin.

    Bluepharma Industria Farmaceutica